Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Virus entry as a target for anti-HIV intervention.
New antiretroviral drugs and approaches to HIV treatment.
Control of glycogen deposition.
RNA interference of HIV replication.
Retroviruses and opportunistic infections - ninth conference. New antiviral agents. 24-28 February, Seattle, WA, USA.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.